Keithaiken (Talk | contribs) |
Keithaiken (Talk | contribs) |
||
Line 12: | Line 12: | ||
<div class="content"> <!--everything added for content goes after this line--> | <div class="content"> <!--everything added for content goes after this line--> | ||
+ | <div class="oneText-Wrapper"> | ||
+ | <div class="oneText-Text"> | ||
+ | <p class="f12">The following constructs are improved by being cloned and confirmed to be into the pSB1C3 plasmid, thus making them able to express in <i>E. coli</i> and used for iGEM user applications. Our project focuses on encapsulation of cargo by protein nanocompartments. This technology can be used to encapsulate cell free systems. The Next Vivo project, designed by the <a href="https://2017.igem.org/Team:Lethbridge">Lethbridge iGEM team </a> in 2017 is therefore an important and viable application for our toolkit. We hope in the future to try encapsulating this system as an alternative to liposome encapsulation as previously proposed for this project. The ability to target cell types could increase the cell free technology we are still developing. </p> | ||
+ | </div> | ||
+ | </div> | ||
− | + | <div style="clear: both"></div> | |
− | + | ||
− | + | <h3><a href="http://parts.igem.org/Part:BBa_K2683016" target="_blank" class="f12">Release Factor 1</a></h3> | |
<img src="https://static.igem.org/mediawiki/2018/9/97/T--Lethbridge--RF1.PNG" alt="RF1 construct"> | <img src="https://static.igem.org/mediawiki/2018/9/97/T--Lethbridge--RF1.PNG" alt="RF1 construct"> | ||
− | <ul style="list-style-type:none"> | + | <ul style="list-style-type:none" class="f11"> |
<li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443029" target="_blank">BBa_K2443029</a></li> | <li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443029" target="_blank">BBa_K2443029</a></li> | ||
<li> Submitted by: Lethbridge iGEM 2017</li> | <li> Submitted by: Lethbridge iGEM 2017</li> | ||
Line 24: | Line 29: | ||
</ul> | </ul> | ||
− | <h3><a href="http://parts.igem.org/Part:BBa_K2683017" target="_blank">Release Factor 2</a></h3> | + | <h3><a href="http://parts.igem.org/Part:BBa_K2683017" target="_blank" class="f12>Release Factor 2</a></h3> |
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
<li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443030" target="_blank">BBa_K2443030</a></li> | <li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443030" target="_blank">BBa_K2443030</a></li> | ||
Line 33: | Line 38: | ||
− | <h3><a href="http://parts.igem.org/Part:BBa_K2683018" target="_blank">Cysteine tRNA Synthetase</a></h3> | + | <h3><a href="http://parts.igem.org/Part:BBa_K2683018" target="_blank" class="f12>Cysteine tRNA Synthetase</a></h3> |
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
<li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443004" target="_blank">BBa_K2443004</a></li> | <li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443004" target="_blank">BBa_K2443004</a></li> | ||
Line 41: | Line 46: | ||
</ul> | </ul> | ||
− | <h3><a href="http://parts.igem.org/Part:BBa_K2683019" target="_blank">Lysine tRNA Synthetase</a></h3> | + | <h3><a href="http://parts.igem.org/Part:BBa_K2683019" target="_blank" class="f12>Lysine tRNA Synthetase</a></h3> |
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
<li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443012" target="_blank">BBa_K2443012</a></li> | <li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443012" target="_blank">BBa_K2443012</a></li> | ||
Line 51: | Line 56: | ||
− | <h3><a href="http://parts.igem.org/Part:BBa_K2683020" target="_blank">Phenylalanine tRNA Synthetase alpha subunit (PheRS alpha) </a></h3> | + | <h3><a href="http://parts.igem.org/Part:BBa_K2683020" target="_blank" class="f12>Phenylalanine tRNA Synthetase alpha subunit (PheRS alpha) </a></h3> |
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
<li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443014" target="_blank">BBa_K2443014</a></li> | <li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443014" target="_blank">BBa_K2443014</a></li> | ||
Line 61: | Line 66: | ||
− | <h3><a href="http://parts.igem.org/Part:BBa_K2683022" target="_blank">Serine tRNA Synthetase (SerRS) </a></h3> | + | <h3><a href="http://parts.igem.org/Part:BBa_K2683022" target="_blank" class="f12>Serine tRNA Synthetase (SerRS) </a></h3> |
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
<li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443019" target="_blank">BBa_K2443019</a></li> | <li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443019" target="_blank">BBa_K2443019</a></li> | ||
Line 71: | Line 76: | ||
− | <h3><a href="http://parts.igem.org/Part:BBa_K2683023" target="_blank">Valine tRNA Synthetase (ValRS) </a></h3> | + | <h3><a href="http://parts.igem.org/Part:BBa_K2683023" target="_blank" class="f12>Valine tRNA Synthetase (ValRS) </a></h3> |
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
<li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443023" target="_blank">BBa_K2443023</a></li> | <li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443023" target="_blank">BBa_K2443023</a></li> | ||
Line 82: | Line 87: | ||
− | <h3><a href="http://parts.igem.org/Part:BBa_K2683024" target="_blank">Initiation Factor I (IF1)</a></h3> | + | <h3><a href="http://parts.igem.org/Part:BBa_K2683024" target="_blank" class="f12>Initiation Factor I (IF1)</a></h3> |
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
<li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443024" target="_blank">BBa_K2443024</a></li> | <li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443024" target="_blank">BBa_K2443024</a></li> | ||
Line 93: | Line 98: | ||
− | <h3><a href="http://parts.igem.org/Part:BBa_K2683025" target="_blank">Initiation Factor 3 (IF1)</a></h3> | + | <h3><a href="http://parts.igem.org/Part:BBa_K2683025" target="_blank" class="f12>Initiation Factor 3 (IF1)</a></h3> |
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
<li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443025" target="_blank">BBa_K2443025</a></li> | <li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443025" target="_blank">BBa_K2443025</a></li> | ||
Line 104: | Line 109: | ||
− | <h3><a href="http://parts.igem.org/Part:BBa_K2683026" target="_blank">Elongation Factor- Thermo Unstable (EF-Tu) </a></h3> | + | <h3><a href="http://parts.igem.org/Part:BBa_K2683026" target="_blank" class="f12>Elongation Factor- Thermo Unstable (EF-Tu) </a></h3> |
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
<li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443027" target="_blank">BBa_K2443027</a></li> | <li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443027" target="_blank">BBa_K2443027</a></li> | ||
Line 114: | Line 119: | ||
− | <h3><a href="http://parts.igem.org/Part:BBa_K2683027" target="_blank">Elongation Factor-Thermo Stable (EF-Ts)</a></h3> | + | <h3><a href="http://parts.igem.org/Part:BBa_K2683027" target="_blank" class="f12>Elongation Factor-Thermo Stable (EF-Ts)</a></h3> |
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
<li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443028" target="_blank">BBa_K2443028</a></li> | <li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443028" target="_blank">BBa_K2443028</a></li> | ||
Line 125: | Line 130: | ||
− | <h3><a href="http://parts.igem.org/Part:BBa_K2683028" target="_blank">MyoKinase (MK)</a></h3> | + | <h3><a href="http://parts.igem.org/Part:BBa_K2683028" target="_blank" class="f12>MyoKinase (MK)</a></h3> |
<img src="https://static.igem.org/mediawiki/2018/c/ce/T--Lethbridge--MK.PNG" alt="MK construct"> | <img src="https://static.igem.org/mediawiki/2018/c/ce/T--Lethbridge--MK.PNG" alt="MK construct"> | ||
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
Line 137: | Line 142: | ||
</ul> | </ul> | ||
− | <h3><a href="http://parts.igem.org/Part:BBa_K2683029" target="_blank">Nucleoside Diphosphate Kinase (NDK)</a></h3> | + | <h3><a href="http://parts.igem.org/Part:BBa_K2683029" target="_blank" class="f12>Nucleoside Diphosphate Kinase (NDK)</a></h3> |
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
<li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443035" target="_blank">BBa_K2443035</a></li> | <li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443035" target="_blank">BBa_K2443035</a></li> | ||
Line 148: | Line 153: | ||
− | <h3><a href="http://parts.igem.org/Part:BBa_K2683030" target="_blank">Peptidyl Prolyl Isomerase (PPiase)</a></h3> | + | <h3><a href="http://parts.igem.org/Part:BBa_K2683030" target="_blank" class="f12>Peptidyl Prolyl Isomerase (PPiase)</a></h3> |
<ul style="list-style-type:none"> | <ul style="list-style-type:none"> | ||
<li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443036" target="_blank">BBa_K2443036</a></li> | <li>Original Part: <a href="http://parts.igem.org/Part:BBa_K2443036" target="_blank">BBa_K2443036</a></li> |
Revision as of 01:11, 18 October 2018
The following constructs are improved by being cloned and confirmed to be into the pSB1C3 plasmid, thus making them able to express in E. coli and used for iGEM user applications. Our project focuses on encapsulation of cargo by protein nanocompartments. This technology can be used to encapsulate cell free systems. The Next Vivo project, designed by the Lethbridge iGEM team in 2017 is therefore an important and viable application for our toolkit. We hope in the future to try encapsulating this system as an alternative to liposome encapsulation as previously proposed for this project. The ability to target cell types could increase the cell free technology we are still developing.
Release Factor 1
- Original Part: BBa_K2443029
- Submitted by: Lethbridge iGEM 2017
- Designed by: iGEM17_Lethbridge
- Brief description: Release factor 1 (RF1) works with release factor 2 and 3 to cause the termination of translation by recognizing the stop codon in the mRNA sequence in question.